# Fluoxetine Opens Window to Improve Motor Recovery After Stroke

> **NCT03448159** · PHASE2 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 52 (actual)

## Conditions studied

- Stroke
- Cerebrovascular Accident
- Cerebral Infarction
- Brain Infarction
- Brain Ischemia
- Cerebrovascular Disorders
- Brain Diseases
- Central Nervous System Diseases
- Nervous System Diseases
- Vascular Diseases

## Interventions

- **DRUG:** Fluoxetine Hydrochloride
- **OTHER:** Placebo
- **BEHAVIORAL:** Exercise Program

## Key facts

- **NCT ID:** NCT03448159
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-01
- **Primary completion:** 2022-09-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2022-11-04

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03448159

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03448159, "Fluoxetine Opens Window to Improve Motor Recovery After Stroke". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03448159. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*